1 Study Coverage 1.1 Cell-Free DNA (cfDNA) Testing Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022) & (US$ Million) Introduction 1.2 Global Cell-Free DNA (cfDNA) Testing Outlook 2017 VS 2022 VS 2028 1.2.1 Global Cell-Free DNA (cfDNA) Testing Market Size for the Year 2017-2028 1.2.2 Global Cell-Free DNA (cfDNA) Testing Market Size for the Year 2017-2028 1.3 Cell-Free DNA (cfDNA) Testing Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.3.1 The Market Share of United States Cell-Free DNA (cfDNA) Testing in Global, 2017 VS 2022 VS 2028 1.3.2 The Growth Rate of Cell-Free DNA (cfDNA) Testing Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.4 Cell-Free DNA (cfDNA) Testing Market Dynamics 1.4.1 Cell-Free DNA (cfDNA) Testing Industry Trends 1.4.2 Cell-Free DNA (cfDNA) Testing Market Drivers 1.4.3 Cell-Free DNA (cfDNA) Testing Market Challenges 1.4.4 Cell-Free DNA (cfDNA) Testing Market Restraints 1.5 Study Objectives 1.6 Years Considered 2 Cell-Free DNA (cfDNA) Testing by Type 2.1 Cell-Free DNA (cfDNA) Testing Market Segment by Type 2.1.1 Donor-Derived Cell-Free DNA (DdcfDNA) 2.1.2 Circulating Cell-Free Tumor DNA (CtDNA) 2.1.3 Cell-Free Fetal DNA (NIPT) 2.2 Global Cell-Free DNA (cfDNA) Testing Market Size by Type (2017, 2022 & 2028) 2.3 Global Cell-Free DNA (cfDNA) Testing Market Size by Type (2017-2028) 2.4 United States Cell-Free DNA (cfDNA) Testing Market Size by Type (2017, 2022 & 2028) 2.5 United States Cell-Free DNA (cfDNA) Testing Market Size by Type (2017-2028) 3 Cell-Free DNA (cfDNA) Testing by Application 3.1 Cell-Free DNA (cfDNA) Testing Market Segment by Application 3.1.1 Hospital 3.1.2 Ambulatory Surgical Centers 3.1.3 Cancer Research Institutes 3.2 Global Cell-Free DNA (cfDNA) Testing Market Size by Application (2017, 2022 & 2028) 3.3 Global Cell-Free DNA (cfDNA) Testing Market Size by Application (2017-2028) 3.4 United States Cell-Free DNA (cfDNA) Testing Market Size by Application (2017, 2022 & 2028) 3.5 United States Cell-Free DNA (cfDNA) Testing Market Size by Application (2017-2028) 4 Global Cell-Free DNA (cfDNA) Testing Competitor Landscape by Company 4.1 Global Cell-Free DNA (cfDNA) Testing Market Size by Company 4.1.1 Top Global Cell-Free DNA (cfDNA) Testing Companies Ranked by Revenue (2021) 4.1.2 Global Cell-Free DNA (cfDNA) Testing Revenue by Player (2017-2022) 4.2 Global Cell-Free DNA (cfDNA) Testing Concentration Ratio (CR) 4.2.1 Cell-Free DNA (cfDNA) Testing Market Concentration Ratio (CR) (2017-2022) 4.2.2 Global Top 5 and Top 10 Largest Companies of Cell-Free DNA (cfDNA) Testing in 2021 4.2.3 Global Cell-Free DNA (cfDNA) Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.3 Global Cell-Free DNA (cfDNA) Testing Headquarters, Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022) & (US$ Million) Type 4.3.1 Global Cell-Free DNA (cfDNA) Testing Headquarters and Area Served 4.3.2 Global Cell-Free DNA (cfDNA) Testing Companies Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022) & (US$ Million) Type 4.3.3 Date of International Companies Enter into Cell-Free DNA (cfDNA) Testing Market 4.4 Companies Mergers & Acquisitions, Expansion Plans 4.5 United States Cell-Free DNA (cfDNA) Testing Market Size by Company 4.5.1 Top Cell-Free DNA (cfDNA) Testing Players in United States, Ranked by Revenue (2021) 4.5.2 United States Cell-Free DNA (cfDNA) Testing Revenue by Players (2020, 2021 & 2022) 5 Global Cell-Free DNA (cfDNA) Testing Market Size by Region 5.1 Global Cell-Free DNA (cfDNA) Testing Market Size by Region: 2017 VS 2022 VS 2028 5.2 Global Cell-Free DNA (cfDNA) Testing Market Size by Region (2017-2028) 5.2.1 Global Cell-Free DNA (cfDNA) Testing Market Size by Region: 2017-2022 5.2.2 Global Cell-Free DNA (cfDNA) Testing Market Size by Region (2023-2028) 6 Segment in Region Level & Country Level 6.1 North America 6.1.1 North America Cell-Free DNA (cfDNA) Testing Market Size YoY Growth 2017-2028 6.1.2 North America Cell-Free DNA (cfDNA) Testing Market Facts & Figures by Country (2017, 2022 & 2028) 6.1.3 U.S. 6.1.4 Canada 6.2 Asia-Pacific 6.2.1 Asia-Pacific Cell-Free DNA (cfDNA) Testing Market Size YoY Growth 2017-2028 6.2.2 Asia-Pacific Cell-Free DNA (cfDNA) Testing Market Facts & Figures by Region (2017, 2022 & 2028) 6.2.3 China 6.2.4 Japan 6.2.5 South Korea 6.2.6 India 6.2.7 Australia 6.2.8 Taiwan 6.2.9 Indonesia 6.2.10 Thailand 6.2.11 Malaysia 6.2.12 Philippines 6.3 Europe 6.3.1 Europe Cell-Free DNA (cfDNA) Testing Market Size YoY Growth 2017-2028 6.3.2 Europe Cell-Free DNA (cfDNA) Testing Market Facts & Figures by Country (2017, 2022 & 2028) 6.3.3 Germany 6.3.4 France 6.3.5 U.K. 6.3.6 Italy 6.3.7 Russia 6.4 Latin America 6.4.1 Latin America Cell-Free DNA (cfDNA) Testing Market Size YoY Growth 2017-2028 6.4.2 Latin America Cell-Free DNA (cfDNA) Testing Market Facts & Figures by Country (2017, 2022 & 2028) 6.4.3 Mexico 6.4.4 Brazil 6.4.5 Argentina 6.5 Middle East and Africa 6.5.1 Middle East and Africa Cell-Free DNA (cfDNA) Testing Market Size YoY Growth 2017-2028 6.5.2 Middle East and Africa Cell-Free DNA (cfDNA) Testing Market Facts & Figures by Country (2017, 2022 & 2028) 6.5.3 Turkey 6.5.4 Saudi Arabia 6.5.5 U.A.E 7 Company Profiles 7.1 Agilent Technology 7.1.1 Agilent Technology Company Details 7.1.2 Agilent Technology Business Overview 7.1.3 Agilent Technology Cell-Free DNA (cfDNA) Testing Introduction 7.1.4 Agilent Technology Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022) 7.1.5 Agilent Technology Recent Development 7.2 Allenex 7.2.1 Allenex Company Details 7.2.2 Allenex Business Overview 7.2.3 Allenex Cell-Free DNA (cfDNA) Testing Introduction 7.2.4 Allenex Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022) 7.2.5 Allenex Recent Development 7.3 Biocept 7.3.1 Biocept Company Details 7.3.2 Biocept Business Overview 7.3.3 Biocept Cell-Free DNA (cfDNA) Testing Introduction 7.3.4 Biocept Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022) 7.3.5 Biocept Recent Development 7.4 Biodesix 7.4.1 Biodesix Company Details 7.4.2 Biodesix Business Overview 7.4.3 Biodesix Cell-Free DNA (cfDNA) Testing Introduction 7.4.4 Biodesix Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022) 7.4.5 Biodesix Recent Development 7.5 CareDx 7.5.1 CareDx Company Details 7.5.2 CareDx Business Overview 7.5.3 CareDx Cell-Free DNA (cfDNA) Testing Introduction 7.5.4 CareDx Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022) 7.5.5 CareDx Recent Development 7.6 Guardant Health 7.6.1 Guardant Health Company Details 7.6.2 Guardant Health Business Overview 7.6.3 Guardant Health Cell-Free DNA (cfDNA) Testing Introduction 7.6.4 Guardant Health Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022) 7.6.5 Guardant Health Recent Development 7.7 Illumania 7.7.1 Illumania Company Details 7.7.2 Illumania Business Overview 7.7.3 Illumania Cell-Free DNA (cfDNA) Testing Introduction 7.7.4 Illumania Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022) 7.7.5 Illumania Recent Development 7.8 Invited 7.8.1 Invited Company Details 7.8.2 Invited Business Overview 7.8.3 Invited Cell-Free DNA (cfDNA) Testing Introduction 7.8.4 Invited Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022) 7.8.5 Invited Recent Development 7.9 Natera 7.9.1 Natera Company Details 7.9.2 Natera Business Overview 7.9.3 Natera Cell-Free DNA (cfDNA) Testing Introduction 7.9.4 Natera Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022) 7.9.5 Natera Recent Development 7.10 Quest Diagnostics 7.10.1 Quest Diagnostics Company Details 7.10.2 Quest Diagnostics Business Overview 7.10.3 Quest Diagnostics Cell-Free DNA (cfDNA) Testing Introduction 7.10.4 Quest Diagnostics Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022) 7.10.5 Quest Diagnostics Recent Development 7.11 Roche Holdings 7.11.1 Roche Holdings Company Details 7.11.2 Roche Holdings Business Overview 7.11.3 Roche Holdings Cell-Free DNA (cfDNA) Testing Introduction 7.11.4 Roche Holdings Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022) 7.11.5 Roche Holdings Recent Development 7.12 Sequenom 7.12.1 Sequenom Company Details 7.12.2 Sequenom Business Overview 7.12.3 Sequenom Cell-Free DNA (cfDNA) Testing Introduction 7.12.4 Sequenom Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022) 7.12.5 Sequenom Recent Development 7.13 Trovagene 7.13.1 Trovagene Company Details 7.13.2 Trovagene Business Overview 7.13.3 Trovagene Cell-Free DNA (cfDNA) Testing Introduction 7.13.4 Trovagene Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022) 7.13.5 Trovagene Recent Development 8 Research Findings and Conclusion 9 Appendix 9.1 Research Methodology 9.1.1 Methodology/Research Approach 9.1.2 Data Source 9.2 Author Details 9.3 Disclaimer

List of Tables Table 1. Cell-Free DNA (cfDNA) Testing Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028) Table 2. Cell-Free DNA (cfDNA) Testing Market Trends Table 3. Cell-Free DNA (cfDNA) Testing Market Drivers Table 4. Cell-Free DNA (cfDNA) Testing Market Challenges Table 5. Cell-Free DNA (cfDNA) Testing Market Restraints Table 6. Global Cell-Free DNA (cfDNA) Testing Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 7. United States Cell-Free DNA (cfDNA) Testing Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 8. Global Cell-Free DNA (cfDNA) Testing Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 9. United States Cell-Free DNA (cfDNA) Testing Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 10. Top Cell-Free DNA (cfDNA) Testing Companies in Global Market, Ranking by Revenue (2021) Table 11. Global Cell-Free DNA (cfDNA) Testing Revenue by Player, (US$ Million), 2017-2022 Table 12. Global Cell-Free DNA (cfDNA) Testing Revenue Share by Player, 2017-2022 Table 13. Global Cell-Free DNA (cfDNA) Testing Companies Market Concentration Ratio (CR5 and HHI) Table 14. Global Cell-Free DNA (cfDNA) Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell-Free DNA (cfDNA) Testing as of 2021) Table 15. Top Players of Cell-Free DNA (cfDNA) Testing in Global Market, Headquarters and Area Served Table 16. Companies Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022) & (US$ Million) Type Table 17. Date of International Companies Enter into Cell-Free DNA (cfDNA) Testing Market Table 18. Companies Mergers & Acquisitions, Expansion Plans Table 19. Top Cell-Free DNA (cfDNA) Testing Players in United States Market, Ranking by Revenue (2021) Table 20. United States Cell-Free DNA (cfDNA) Testing Revenue by Players, (US$ Million), 2020, 2021 & 2022 Table 21. United States Cell-Free DNA (cfDNA) Testing Revenue Share by Players, 2020, 2021 & 2022 Table 22. Global Cell-Free DNA (cfDNA) Testing Market Size by Region (US$ Million): 2017 VS 2022 VS 2028 Table 23. Global Cell-Free DNA (cfDNA) Testing Market Size by Region (2017-2022) & (US$ Million) Table 24. Global Cell-Free DNA (cfDNA) Testing Market Size Forecast by Region (2023-2028) & (US$ Million) Table 25. North America Cell-Free DNA (cfDNA) Testing Sales in Value by Country (2017-2028) & (US$ Million) Table 26. Asia Pacific Cell-Free DNA (cfDNA) Testing Sales in Value by Region (2017-2028) & (US$ Million) Table 27. Europe Cell-Free DNA (cfDNA) Testing Sales in Value by Country (2017-2028) & (US$ Million) Table 28. Latin Americaa Cell-Free DNA (cfDNA) Testing Sales in Value by Country (2017-2028) & (US$ Million) Table 29. Middle East and Africa Cell-Free DNA (cfDNA) Testing Sales in Value by Country (2017-2028) & (US$ Million) Table 30. Agilent Technology Company Details Table 31. Agilent Technology Business Overview Table 32. Agilent Technology Cell-Free DNA (cfDNA) Testing Product Table 33. Agilent Technology Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022) & (US$ Million) Table 34. Agilent Technology Recent Development Table 35. Allenex Company Details Table 36. Allenex Business Overview Table 37. Allenex Cell-Free DNA (cfDNA) Testing Product Table 38. Allenex Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022) & (US$ Million) Table 39. Allenex Recent Development Table 40. Biocept Company Details Table 41. Biocept Business Overview Table 42. Biocept Cell-Free DNA (cfDNA) Testing Product Table 43. Biocept Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022) & (US$ Million) Table 44. Biocept Recent Development Table 45. Biodesix Company Details Table 46. Biodesix Business Overview Table 47. Biodesix Cell-Free DNA (cfDNA) Testing Product Table 48. Biodesix Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022) & (US$ Million) Table 49. Biodesix Recent Development Table 50. CareDx Company Details Table 51. CareDx Business Overview Table 52. CareDx Cell-Free DNA (cfDNA) Testing Product Table 53. CareDx Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022) & (US$ Million) Table 54. CareDx Recent Development Table 55. Guardant Health Company Details Table 56. Guardant Health Business Overview Table 57. Guardant Health Cell-Free DNA (cfDNA) Testing Product Table 58. Guardant Health Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022) & (US$ Million) Table 59. Guardant Health Recent Development Table 60. Illumania Company Details Table 61. Illumania Business Overview Table 62. Illumania Cell-Free DNA (cfDNA) Testing Product Table 63. Illumania Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022) & (US$ Million) Table 64. Illumania Recent Development Table 65. Invited Company Details Table 66. Invited Business Overview Table 67. Invited Cell-Free DNA (cfDNA) Testing Product Table 68. Invited Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022) & (US$ Million) Table 69. Invited Recent Development Table 70. Natera Company Details Table 71. Natera Business Overview Table 72. Natera Cell-Free DNA (cfDNA) Testing Product Table 73. Natera Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022) & (US$ Million) Table 74. Natera Recent Development Table 75. Quest Diagnostics Company Details Table 76. Quest Diagnostics Business Overview Table 77. Quest Diagnostics Cell-Free DNA (cfDNA) Testing Product Table 78. Quest Diagnostics Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022) & (US$ Million) Table 79. Quest Diagnostics Recent Development Table 80. Roche Holdings Company Details Table 81. Roche Holdings Business Overview Table 82. Roche Holdings Cell-Free DNA (cfDNA) Testing Product Table 83. Roche Holdings Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022) & (US$ Million) Table 84. Roche Holdings Recent Development Table 85. Sequenom Company Details Table 86. Sequenom Business Overview Table 87. Sequenom Cell-Free DNA (cfDNA) Testing Product Table 88. Sequenom Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022) & (US$ Million) Table 89. Sequenom Recent Development Table 90. Trovagene Company Details Table 91. Trovagene Business Overview Table 92. Trovagene Cell-Free DNA (cfDNA) Testing Product Table 93. Trovagene Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022) & (US$ Million) Table 94. Trovagene Recent Development Table 95. Research Programs/Design for This Report Table 96. Key Data Information from Secondary Sources Table 97. Key Data Information from Primary Sources List of Figures Figure 1. Cell-Free DNA (cfDNA) Testing Product Picture Figure 2. Global Cell-Free DNA (cfDNA) Testing Market Size, (US$ Million), 2017 VS 2022 VS 2028 Figure 3. Global Cell-Free DNA (cfDNA) Testing Market Size 2017-2028 (US$ Million) Figure 4. United States Cell-Free DNA (cfDNA) Testing Market Size, (US$ Million), 2017 VS 2022 VS 2028 Figure 5. United States Cell-Free DNA (cfDNA) Testing Market Size 2017-2028 (US$ Million) Figure 6. United States Cell-Free DNA (cfDNA) Testing Market Share in Global 2017-2028 Figure 7. Cell-Free DNA (cfDNA) Testing Report Years Considered Figure 8. Product Picture of Donor-Derived Cell-Free DNA (DdcfDNA) Figure 9. Product Picture of Circulating Cell-Free Tumor DNA (CtDNA) Figure 10. Product Picture of Cell-Free Fetal DNA (NIPT) Figure 11. Global Cell-Free DNA (cfDNA) Testing Market Share by Type in 2022 & 2028 Figure 12. Global Cell-Free DNA (cfDNA) Testing Market Size by Type (2017-2028) & (US$ Million) Figure 13. Global Cell-Free DNA (cfDNA) Testing Market Share by Type (2017-2028) Figure 14. United States Cell-Free DNA (cfDNA) Testing Market Share by Type in 2022 & 2028 Figure 15. United States Cell-Free DNA (cfDNA) Testing Market Size by Type (2017-2028) & (US$ Million) Figure 16. United States Cell-Free DNA (cfDNA) Testing Market Share by Type (2017-2028) Figure 17. Product Picture of Hospital Figure 18. Product Picture of Ambulatory Surgical Centers Figure 19. Product Picture of Cancer Research Institutes Figure 20. Global Cell-Free DNA (cfDNA) Testing Market Share by Application in 2022 & 2028 Figure 21. Global Cell-Free DNA (cfDNA) Testing Market Size by Application (2017-2028) & (US$ Million) Figure 22. Global Cell-Free DNA (cfDNA) Testing Market Share by Application (2017-2028) Figure 23. United States Cell-Free DNA (cfDNA) Testing Market Share by Application in 2022 & 2028 Figure 24. United States Cell-Free DNA (cfDNA) Testing Market Size by Application (2017-2028) & (US$ Million) Figure 25. United States Cell-Free DNA (cfDNA) Testing Market Share by Application (2017-2028) Figure 26. North America Cell-Free DNA (cfDNA) Testing Market Size Growth Rate 2017-2028 (US$ Million) Figure 27. U.S. Cell-Free DNA (cfDNA) Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 28. Canada Cell-Free DNA (cfDNA) Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 29. Europe Cell-Free DNA (cfDNA) Testing Market Size Growth Rate 2017-2028 (US$ Million) Figure 30. Germany Cell-Free DNA (cfDNA) Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 31. France Cell-Free DNA (cfDNA) Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 32. U.K. Cell-Free DNA (cfDNA) Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 33. Italy Cell-Free DNA (cfDNA) Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 34. Russia Cell-Free DNA (cfDNA) Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 35. Asia-Pacific Cell-Free DNA (cfDNA) Testing Market Size Growth Rate 2017-2028 (US$ Million) Figure 36. China Cell-Free DNA (cfDNA) Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 37. Japan Cell-Free DNA (cfDNA) Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 38. South Korea Cell-Free DNA (cfDNA) Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 39. India Cell-Free DNA (cfDNA) Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 40. Australia Cell-Free DNA (cfDNA) Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 41. Taiwan Cell-Free DNA (cfDNA) Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 42. Indonesia Cell-Free DNA (cfDNA) Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 43. Thailand Cell-Free DNA (cfDNA) Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 44. Malaysia Cell-Free DNA (cfDNA) Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 45. Philippines Cell-Free DNA (cfDNA) Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 46. Latin America Cell-Free DNA (cfDNA) Testing Market Size Growth Rate 2017-2028 (US$ Million) Figure 47. Mexico Cell-Free DNA (cfDNA) Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 48. Brazil Cell-Free DNA (cfDNA) Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 49. Argentina Cell-Free DNA (cfDNA) Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 50. Middle East & Africa Cell-Free DNA (cfDNA) Testing Market Size Growth Rate 2017-2028 (US$ Million) Figure 51. Turkey Cell-Free DNA (cfDNA) Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 52. Saudi Arabia Cell-Free DNA (cfDNA) Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 53. U.A.E Cell-Free DNA (cfDNA) Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 54. Agilent Technology Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2017-2022) Figure 55. Allenex Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2017-2022) Figure 56. Biocept Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2017-2022) Figure 57. Biodesix Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2017-2022) Figure 58. CareDx Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2017-2022) Figure 59. Guardant Health Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2017-2022) Figure 60. Illumania Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2017-2022) Figure 61. Invited Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2017-2022) Figure 62. Natera Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2017-2022) Figure 63. Quest Diagnostics Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2017-2022) Figure 64. Roche Holdings Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2017-2022) Figure 65. Sequenom Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2017-2022) Figure 66. Trovagene Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2017-2022) Figure 67. Bottom-up and Top-down Approaches for This Report Figure 68. Data Triangulation Figure 69. Key Executives Interviewed

Agilent Technology Allenex Biocept Biodesix CareDx Guardant Health Illumania Invited Natera Quest Diagnostics Roche Holdings Sequenom Trovagene